News

Researchers are one-step closer to finding the ultimate weight loss treatment – a signal in the human body that stops us from overeating.

Clinical trials found that it is safe to regularly infuse brain and lung cancer patients with 800—1000 times the daily recommended amount of vitamin C as a potential strategy to improve outcomes of standard cancer treatments. In a work presented March 30, 2017 in Cancer Cell, University of Iowa researchers also show pathways by which altered iron metabolism in cancer cells, and not normal cells, lead to increased sensitivity to cancer cell death caused by high dose vitamin C.

Musk's latest project is called Neuralink and its goal is to explore technology that can make direct connections between a human brain and a computer.

Researchers from the University of Birmingham and Newcastle University found that the unusual approach of removing antibodies from the blood stream reduced the effects of chronic infections, the requirement for days spent in hospital and the use of antibiotics.

Doctors from the University of Western Ontario report that in one patient in a Canadian intensive care unit, persistent brain activity was found even after clinical death had been officially declared.

A team of researchers at Boston University has developed a new way to engineer mammalian cells that allows for programming them to behave in desired ways.

Strategy could provide roadmap for promoting innervation in regenerative medicine

Scientists have resolved a key question in aging research by showing how mouse immune cells of different ages respond to stimulation. Study demonstrates weaker response of older cells is due to their coordination breaking down, making their response to immune stimulation more variable. Single-cell sequencing technology allows scientists to profile individual cells independently to view cellular activity in high resolution.

Workplace exposure to electromagentic fields is linked to a higher risk of developing the most common form of motor neurone disease

FDA approves a new drug to treat both relapsing-remitting multiple sclerosis and primary progressive MS.